Evidence map›Paper›PMID 31392383›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2020

Crocin attenuates isoprenaline-induced myocardial fibrosis by targeting TLR4/NF-κB signaling: connecting oxidative stress, inflammation, and apoptosis.

Weiyue Jin, Yuanyuan Zhang, Yurun Xue, Xue Han, Xuan Zhang, Zhihong Ma, Shijiang Sun, Xi Chu, Jie Cheng, Shengjiang Guan and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Protective Effects of 2-Methoxyestradiol on Acute Isoproterenol-Induced Cardiac Injury in Rats.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Weiyue JinSchool of Basic Medicine, Hebei University of Chinese Medicine, 6 Xingyuan Road, Shijiazhuang, 050200, Hebei, People's Republic of China.
Yuanyuan ZhangSchool of Pharmacy, Hebei University of Chinese Medicine, 6 Xingyuan Road, Shijiazhuang, 050200, Hebei, People's Republic of China.
Yurun XueSchool of Basic Medicine, Hebei University of Chinese Medicine, 6 Xingyuan Road, Shijiazhuang, 050200, Hebei, People's Republic of China.
Xue HanSchool of Pharmacy, Hebei University of Chinese Medicine, 6 Xingyuan Road, Shijiazhuang, 050200, Hebei, People's Republic of China.
Xuan ZhangSchool of Basic Medicine, Hebei University of Chinese Medicine, 6 Xingyuan Road, Shijiazhuang, 050200, Hebei, People's Republic of China.
Zhihong MaSchool of Basic Medicine, Hebei University of Chinese Medicine, 6 Xingyuan Road, Shijiazhuang, 050200, Hebei, People's Republic of China.
Shijiang SunAffiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, 050011, Hebei, China.
Xi ChuDepartment of Pharmacy, The Fourth Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, 050011, Hebei, China.
Jie ChengAffiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, 050011, Hebei, China.
Shengjiang GuanSchool of Basic Medicine, Hebei University of Chinese Medicine, 6 Xingyuan Road, Shijiazhuang, 050200, Hebei, People's Republic of China. guanshengjiang123@126.com.
Ziliang LiSchool of Basic Medicine, Hebei University of Chinese Medicine, 6 Xingyuan Road, Shijiazhuang, 050200, Hebei, People's Republic of China. liziliang321@126.com.
Li ChuSchool of Pharmacy, Hebei University of Chinese Medicine, 6 Xingyuan Road, Shijiazhuang, 050200, Hebei, People's Republic of China. chuli0614@126.com.ORCID 0000-0002-6301-2709
Hebei University of Chinese Medicine · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crocin is isolated from saffron and has multiple activities. There are many reports on its beneficial effects for cardiovascular disease, but crocin's effects on anti-myocardial fibrosis have not yet been reported. This study investigated crocin's effects and potential mechanisms on isoproterenol (ISO)-induced myocardial fibrosis (MF) in mice. Mice were infused intraperitoneally with crocin with concurrent ISO subcutaneous injections over 2 weeks. Electrocardiography, cardiac weight index (CWI), hydroxyproline content, and heart morphology changes were observed. Administration of crocin markedly decreased heart rate, J-point elevation, QRS interval, CWI, and hydroxyproline content in the myocardial tissues, and improved heart pathologic morphology. Versus the control group, the ISO group showed an increase in lactate dehydrogenase and creatine kinase activities and malondialdehyde content. Meanwhile, superoxide dismutase, catalase, and glutathione contents decreased in the ISO group; crocin caused a significant reduction in oxidative stress levels in ISO-induced MF. ISO led to a significant increase in interleukin-1 and -6 and tumor necrosis factor-α in addition to nuclear factor kappa B (NF-κB) (p65) and toll-like receptor (TLR) 4 expressions. Crocin treatment suppressed these inflammatory cytokine expressions. Moreover, crocin treatment caused a significant decrease in connective tissue growth factor and transforming growth factor-β1 mRNA levels in addition to a decrease in B cell lymphoma-2, Bcl-2-associated X protein, caspase-3, and cleaved caspase-3 expressions. Crocin has a protective effect on ISO-induced MF, which may be associated with the TLR4/NF-κB (p65) signal transduction pathway.

Indexed as

AnimalsAnti-Inflammatory AgentsCardiomyopathiesCardiotonic AgentsCarotenoidsFibrosisIsoproterenolMaleMiceMyocardiumNF-kappa BOxidative StressSignal TransductionToll-Like Receptor 4Transforming Growth Factor beta1Anti-Inflammatory AgentsCardiotonic AgentsCarotenoidscrocinIsoproterenolNF-kappa BTgfb1 protein, mouseTlr4 protein, mouseToll-Like Receptor 4Transforming Growth Factor beta1CrocinIsoproterenolMyocardial fibrosisOxidative stressTLR4/NF-κB

Identifiers

PMID31392383
OpenAlexW2964556118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.